OUR FIRST EXPERIENCE OF ONCOTYPE DX IN EARLY BREAST CANCER

被引：0
|
作者：
Khawaja, S. [1 ]
Sharaiha, Y. [1 ]
Pitcher, S. [1 ]
Whelan, S. [2 ]
Brinkworth, E. [2 ]
Pudney, D. [2 ]
Moe, M. [2 ]
Rolles, M. [2 ]
Bertelli, G. [2 ]
Holt, S. [1 ]
机构：
[1] Prince Philip Hosp, Breast Unit, Llanelli, Wales
[2] Singleton Hosp, Swansea SA2 8QA, W Glam, Wales
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [41] Investigating the Role of Oncotype DX in the Treatment of Early Stage Luminal A Breast
    Hughes, L.
    Mcveigh, T.
    Keane, M.
    Sweeney, K.
    Kerin, M.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 17 - 17
  • [42] Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK
    Loncaster, J.
    Armstrong, A.
    Howell, S.
    Wilson, G.
    Welch, R.
    Chittalia, A.
    Valentine, W. J.
    Bundred, N. J.
    EJSO, 2017, 43 (05): : 931 - 937
  • [43] Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the BC experience
    Baxter, E.
    Gondara, L.
    Lohrisch, C.
    Chia, S.
    Gelmon, K.
    Hayes, M.
    Davidson, A.
    Tyldesley, S.
    CURRENT ONCOLOGY, 2015, 22 (03) : 192 - 198
  • [44] Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
    Joshua A. Bloom
    Yurie Sekigami
    Rebekah Young
    Lisa Macera
    Christy A. Russell
    Yu Cao
    Rachel J. Buchsbaum
    Stephen P. Naber
    Abhishek Chatterjee
    Annals of Surgical Oncology, 2021, 28 : 8711 - 8716
  • [45] Discordance in Oncotype DX Breast Recurrence Score Results for Bilateral Breast Cancer
    Bloom, J. A.
    Sekigami, Y.
    Cao, Y.
    Buchsbaum, R. J.
    Naber, S. P.
    Chatterjee, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S51 - S51
  • [46] Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use
    Evelien Schaafsma
    Baoyi Zhang
    Merit Schaafsma
    Chun-Yip Tong
    Lanjing Zhang
    Chao Cheng
    Breast Cancer Research, 23
  • [47] Impact of Oncotype DX testing on ER plus breast cancer treatment and survival in the first decade of use
    Schaafsma, Evelien
    Zhang, Baoyi
    Schaafsma, Merit
    Tong, Chun-Yip
    Zhang, Lanjing
    Cheng, Chao
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [48] Correlation between Oncotype DX recurrence score and classical risk factors in early breast cancer.
    Namuche, Fernando
    Mendoza, Rossana Esther Ruiz
    Flores, Claudio J.
    Aguilar, Alfredo
    Gomez, Henry Leonidas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] ONCOTYPE DX® - THE SiRIO-LIBANeS HOSPITAL CANCER CENTER EXPERIENCE
    Pereira, A. A. L.
    Shimada, A. K.
    Santini, F. C.
    Nascimento, E. C.
    Ribeiro, K. B.
    Marques, R. J.
    Mano, M. S.
    Katz, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 112 - 112
  • [50] Utilization of oncotype DX for breast cancer in different facility types in Louisiana
    Loch, M.
    Li, X.
    Mumphrey, B.
    Garcia, A.
    Wu, X-C
    CANCER RESEARCH, 2017, 77
12345